Omnicell Inc (OMCL) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.

Total Revenue Chart for Omnicell Inc

Omnicell Inc (OMCL) revenue for FY2025 was USD 1.2B, a 6.5% change from FY2024. Omnicell Inc's revenue grew from USD 67.4M in 2000 to USD 1.2B in 2025 (1658.8% over 25 years). Earnings per share grew from USD 0.29 in 2003 to USD 0.12 in 2022 (-57.4%). Revenue compound annual growth rate: 5-year CAGR of 5.8%, 10-year CAGR of 9.4%, 20-year CAGR of 12.1%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.72B
Implied Share Price
$37.75
Enterprise Value
$1.41B
Revenue (TTM)
$1.25B
EBITDA
$82.18M
Profit Margin
3.14%
Trailing P/E
44.94
Forward P/E
29.50
Price/Book (MRQ)
1.17
Price/Sales (TTM)
1.38
EV/EBITDA
9.87
EV/Revenue
1.13
Dividend Yield
—
Book Value
$28.32
Free Cash Flow (FY2025)
$86.89M
Free Cash Flow Yield
5.06%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.